Cognitive impairment in primary brain tumors outpatients: A prospective cross-sectional survey

Journal of Neuro-Oncology

Volumn 112, Issue 3, 2013, Pages 455-460

  Zucchella, Chiara ^a   Bartolo, Michelangelo ^b   Di Lorenzo, Cherubino ^a   Villani, Veronica ^a   Pace, Andrea ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Brain tumor; Cognitive deficits; Neuro oncology; Neuropsychology

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BEVACIZUMAB; CORTICOSTEROID; TEMOZOLOMIDE;

ADULT; BRAIN TUMOR; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LANGUAGE; LIFE EXPECTANCY; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REVIEW; SURVIVAL TIME; WORKING MEMORY;

AGE FACTORS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEUROSURGICAL PROCEDURES; PROSPECTIVE STUDIES; RADIOTHERAPY;

EID: 84885048424     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1076-8     Document Type: Review

References (53)

1. Bell KR, O'Dell MW, Barr K, Yablon SA (1998) Rehabilitation of the patient with brain tumor. Arch Phys Med Rehabil 79:S37-S46
2. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB (2001) Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil 80:346-350
3. Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ (2002) Effect of radiotherapy and other treatment-related factors on mild-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361-1368
4. Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324-333
5. Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, Cleijne W, Aaronson NK (2001) Neurobehavioural status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19:4037-4047
6. Taphoorn MJB (2003) Neurocognitive sequelae in the treatment of low-grade gliomas. Semin Oncol 30(6 Suppl 19):45-48
7. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157-165
8. van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC (2007) Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 84:271-278
9. Talacchi A, Santini B, Savazzi S, Gerosa M (2011) Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103:541-549
10. Torres IJ, Mundt AJ, Sweeney PJ, Llanes-Macy S, Dunaway L, Castillo M, Macdonald RL (2003) A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60:1113-1118
11. Brown PD, Jensen AW, Felten SJ, Ballman KV, Schaefer PL, Jaeckle KA, Cerhan JH, Buckner JC (2006) Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 24:5427-5433
12. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159-168
13. Biegler KA, Chaoul MA, Cohen L (2009) Cancer, cognitive impairment, and meditation. Acta Oncol 48(1):18-26
14. Locke DEC, Cerhan JH, Wu W, Malec JF, Clark MM, Rummans TA, Brown PD (2008) Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. J Support Oncol 6:383-391
15. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992-999
16. Weitzner MA, Meyers CA (1997) Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology 6:169-177
17. Gustaffson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 14:1205-1212
18. Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76(4):562-568
19. Meyers CA, Hess KR (2003) Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol 5(2):89-95
20. Wefel JS, Witgert ME, Meyers CA (2008) Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18(2):121-131
21. Giovagnoli AR (2012) Investigation of cognitive impairments in people with brain tumors. J Neurooncol 108(2):277-283
22. Triebel KL, Martin RC, Nabors LB, Marson DC (2009) Medical decision-making capacity in patients with malignant glioma. Neurology 73:2086-2092
23. Marson DC, Martin RC, Triebel KL, Nabors LB (2010) Capacity to consent to research participation in adults with malignant glioma. J Clin Oncol 28:3844-3850
24. Folstein MF, Folstein SE, Mc Hugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189-198
25. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G (1987) Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 8(6):539-548
26. Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36(6):378-384
27. Carlesimo GA, Buccione I, Fadda L, Graceffa A, Mauri M, Lo Russo S, Bevilacqua G, Caltagirone C (2002) Standardizzazione di due test di memoria per uso clinico: breve racconto e figura di rey. Nuova Rivista Neurol 12:1-13
28. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A (2002) Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 22:443-447
29. Caffarra P, Vezzadini G, Zonato F, Copelli S (1938) Venneri A (2003) A normative study of a shorter version of Raven's progressive matrices. Neurol Sci 24(5):336-339
30. Apollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108-116
31. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996) Trail making test: normative values from 287 normal adults controls. It J Neurol Sci 17:305-309
32. Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia Neurologia Psichiatria 47:477-506
33. Correa DD (2006) Cognitive functions in brain tumor patients. Hematol Oncol Clin North Am 20:1363-1376
34. Dietrich J, Monje M, Wefel J, Meyers C (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 13(12):1285-1295
35. Heimans JJ, Reijneveld JC (2012) Factors affecting the cerebral network in brain tumor patients. J Neurooncol 108:231-237
36. Stern Y (2009) Cognitive reserve. Neuropsychologia 47(10):2015-2028
37. Steffener J, Stern Y (2012) Exploring the neural basis of cognitive reserve in aging. Biochim Biophys Acta 1822(3):467-473
38. Vataja R, Pohjasvaara T, Mantyla R, Ylikoski R, Leppavuori A, Leskela M, Kalska H, Hietanen M, Aronen HJ, Salonen O, Kaste M, Erkinjuntti T (2003) MRI correlates of executive disfunction in patients with ischaemic stroke. Eur J Neurol 10:625-631
39. Nys GMS, van Zandvoort MJE, de Kort PML, Jansen BPW, de Haan EHF, Kappelle LJ (2007) Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc Dis 23:408-416
40. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639-1651
41. Argyriou AA, Assimakopoulos K, Iconomou G, Giannakopoulou F, Kalofonos HP (2010) Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real. J Pain Symptom Manage 41:126-139
42. Mitchell T, Turton P (2011) 'Chemobrain': concentration and memory effects in people receiving chemotherapy-a descriptive phenomenological study. Eur J Cancer Care 20:539-548
43. Gong X, Schwartz PH, Linskey ME, Bota DA (2011) Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy. Neurology 76:1126-1134
44. Scheibel RS, Meyers CA, Levin AV (1996) Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 30:61-69
45. Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G (2012) Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108(2):291-308
46. Sheline G, WaraWM Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215-1228
47. Behin A, Delattre J-Y (2003) Neurologic sequelae of radiotherapy on the nervous system. In: Schiff D, Wen PY (eds) Cancer neurology in clinical practice. Humana Press Inc., Totowa, pp 173-191
48. Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18:646-650
49. Klein M, Postma TJ, Taphoorn MJB, Aaronson NK, Vandertop WP, Muller M, Van der Ploeg HM, Heimans JJ (2003) The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61(12):1796-1799
50. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG (2004) Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 59(1):117-125
51. Armstrong CL, Goldstein B, Shera D, Ledakis GE, Tallent EM (2003) The predictive value of longitudinal neuropsychological assessment in the early detection of brain tumor recurrence. Cancer 97:649-656
52. Meyers CA, Rock EP, Fine HA (2012) Refining endpoints in brain tumor clinical trials. J Neurooncol 108:227-230
53. Klein M, Duffau H, De Witt Hamer PC (2012) Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol 108:309-318